Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Trevi Therapeutics Inc (NQ: TRVI )

1.130 -0.020 (-1.74%)
Streaming Delayed Price Updated: 3:22 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160,781
Open 1.160
Bid (Size) 1.120 (3)
Ask (Size) 1.140 (4)
Prev. Close 1.150
Today's Range 1.100 - 1.200
52wk Range 0.9700 - 3.500
Shares Outstanding 60,069,512
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
Trevi Therapeutics's Earnings: A Preview
Via Benzinga

Performance

YTD
-44.33%
-44.33%
1 Month
-21.53%
-21.53%
3 Month
-46.95%
-46.95%
6 Month
-56.20%
-56.20%
1 Year
-46.95%
-46.95%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Recap: Trevi Therapeutics Q1 Earnings
Via Benzinga
Earnings Preview: Trevi Therapeutics
Via Benzinga
Earnings Outlook For Trevi Therapeutics
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial
Via Benzinga
Earnings Scheduled For May 11, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For August 11, 2022
Via Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 16, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
Via Newsfile
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Outlook For Trevi Therapeutics, Inc. - Common Stock
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For November 10, 2022
Via Benzinga
Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast
Via Newsfile
Exposures Product Safety
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
5 Penny Stocks to Buy on the Dip
Via InvestorPlace
Traders News Source Senior Editor Mark Roberts Interviews Jennifer Good CEO of Trevi Therapeutics
From Traders News Source
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.